ArticleFrontiers in physiology2015

Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling.

Marcondes A B Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.